INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "DEUTERATED COMPOUNDS AND USES THEREOF"

GENEVA, Feb. 17 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1 Doshomachi 4-chome, Chuo-kuOsaka-shi, Osaka 541-0045) filed a patent application (PCT/IB2025/058080) for "DEUTERATED COMPOUNDS AND USES THEREOF" on Aug 07, 2025. With publication no. WO/2026/033474, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEIT DE MORADEI, Silvana M. (c/o Takeda Development Center Americas, Inc.500 Kendall StreetCambridge, Massachusetts 02142)

Abstract: The present invention provides deuterium-enriched tyrosine-protein kinase 2 (TYK2) i...